University of Maryland Researchers Develop Human Challenge Model for Dengue Serotype 4, Advancing Vaccine Research
Researchers at the University of Maryland School of Medicine (UMSOM) and the Institute of Human Virology (IHV) have successfully developed the first human challenge model for dengue serotype 4. This breakthrough, published in The Lancet Microbe, involved administering a low dose of the challenge virus to 14 healthy adult volunteers. All participants developed detectable virus in their blood and experienced mild-to-moderate dengue symptoms, primarily rash and fatigue. The study, conducted between April 2022 and December 2023, also provided insights into the immune system's response to dengue exposure, showing robust antibody responses and activation of antiviral genes after primary infection, which were largely absent upon re-exposure, indicating protection. This model builds upon previous work for dengue serotypes 1 and 3, offering a controlled clinical setting to investigate the distinct characteristics of each serotype and evaluate potential vaccines and therapeutics.